Clinical Trial Update: The Efficacy of Silymarin on the Prevention of Hepatotoxicity From Antituberculosis Drugs [NA]

View source ↗

Summary

A completed clinical trial evaluated whether silymarin can prevent hepatotoxicity from standard antituberculosis therapy in patients with tuberculosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis

Drugs mentioned

• Silymarin (silymarin)

Snippet

Sponsor: Ramathibodi Hospital | Conditions: Tuberculosis | NA | Status: COMPLETED